Korro Bio Inc.

14.52
-0.23 (-1.56%)
At close: Apr 04, 2025, 3:48 PM
-1.56%
Bid 14.09
Market Cap 136.33M
Revenue (ttm) n/a
Net Income (ttm) n/a
EPS (ttm) -9.37
PE Ratio (ttm) -1.55
Forward PE -3.71
Analyst Buy
Ask 14.67
Volume 47,920
Avg. Volume (20D) 87,113
Open 14.71
Previous Close 14.75
Day's Range 13.38 - 14.90
52-Week Range 13.38 - 98.00
Beta 2.31

About KRRO

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts....

Industry Biotechnology
Sector Healthcare
IPO Date Oct 3, 2019
Employees 104
Stock Exchange NASDAQ
Ticker Symbol KRRO
Full Company Profile

Analyst Forecast

According to 6 analyst ratings, the average rating for KRRO stock is "Buy." The 12-month stock price forecast is $117.5, which is an increase of 709.23% from the latest price.

Stock Forecasts
4 months ago
+3.34%
Korro Bio shares are trading higher. HC Wainwright... Unlock content with Pro Subscription
4 months ago
-15.55%
Korro Bio shares are trading lower. The company reported Q3 financial results.